Biotech · Private company
Carrick Therapeutics Limited
Track this companyFree. Adds Carrick Therapeutics Limited to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- CT7001Phase 2 · Advanced Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- CT7439 Capsules (0.5 mg, 1mg, 3mg, 10mg, 15mg, 20mg)Phase 2 · Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Elacestrant DihydrochloridePhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Advanced Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- SamuraciclibPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic CancerPHASE1 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07645651 · fetched Nov 12, 2026
- A Modular Phase 1/2 Study With CT7439 in Participants With Solid MalignanciesPHASE1_PHASE2 · RECRUITING · started Aug 16, 2024ClinicalTrials.gov NCT06600789 · fetched Nov 12, 2026
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)PHASE1_PHASE2 · TERMINATED · started Jan 10, 2024ClinicalTrials.gov NCT06125522 · fetched Nov 12, 2026
- A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult ParticipantsPHASE2 · COMPLETED · started Nov 16, 2023ClinicalTrials.gov NCT05963984 · fetched Nov 12, 2026
- A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast CancerPHASE1_PHASE2 · COMPLETED · started Oct 9, 2023ClinicalTrials.gov NCT05963997 · fetched Nov 12, 2026
- Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced MalignanciesPHASE1_PHASE2 · COMPLETED · started Nov 14, 2017ClinicalTrials.gov NCT03363893 · fetched Nov 12, 2026